| scholarly article | Q13442814 |
| case report | Q2782326 |
| P6179 | Dimensions Publication ID | 1045789865 |
| P356 | DOI | 10.1186/1477-7819-12-358 |
| P932 | PMC publication ID | 4258279 |
| P698 | PubMed publication ID | 25427657 |
| P5875 | ResearchGate publication ID | 268879259 |
| P50 | author | Darko Katalinic | Q60391147 |
| P2093 | author name string | Stjepko Plestina | |
| Antonio Juretic | |||
| Fedor Santek | |||
| Dinko Skegro | |||
| P2860 | cites work | [Neuroendocrine carcinomas of the colon and rectum. A unit's experience over six years] | Q80930073 |
| The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease | Q81290650 | ||
| Colorectal cancer | Q81398612 | ||
| Meckel's diverticulum: a systematic review | Q24672320 | ||
| Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial | Q28036747 | ||
| Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma | Q28264065 | ||
| The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems | Q28289008 | ||
| A systematic review of treatment guidelines for metastatic colorectal cancer | Q33995028 | ||
| Sunitinib malate for the treatment of pancreatic neuroendocrine tumors | Q34163515 | ||
| A 5-decade analysis of 13,715 carcinoid tumors | Q34175374 | ||
| A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. | Q34282412 | ||
| Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Q34301030 | ||
| Neuroendocrine tumours | Q34306644 | ||
| Everolimus for advanced pancreatic neuroendocrine tumors. | Q34399809 | ||
| Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group | Q34511070 | ||
| Imaging manifestations of Meckel's diverticulum | Q34639354 | ||
| Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors | Q35197186 | ||
| Neuroendocrine tumors arising in Meckel's diverticula: frequency of advanced disease warrants aggressive management | Q35626153 | ||
| The diagnosis and medical management of advanced neuroendocrine tumors. | Q35794419 | ||
| An analysis of rare carcinoid tumors: clarifying these clinical conundrums | Q35984573 | ||
| Systemic therapy for colorectal cancer | Q36029007 | ||
| Neuroendocrine tumors: role of interventional radiology in therapy. | Q37219361 | ||
| Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin | Q37653123 | ||
| Gastrointestinal cancer and brain metastasis: a rare and ominous sign | Q37841378 | ||
| Synchronous large-cell neuroendocrine carcinoma and adenocarcinoma of the colon. | Q40606756 | ||
| Neuroendocrine tumors and second primary malignancy--a relationship with clinical impact? | Q42461948 | ||
| Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas | Q44579336 | ||
| Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET. | Q45819756 | ||
| Multimodality palliative treatment of (111)In-pentetreotide negative/(123)I-MIBG positive metastatic carcinoid - a case report. | Q46382258 | ||
| Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients. | Q47924492 | ||
| Octreotide suppression test in diagnosing and predicting the outcome of therapy in patients with neuroendocrine tumors. Preliminary report. | Q51469313 | ||
| Synchronous adenocarcinoma of the lung and neuroendocrine carcinoma of the ileum. | Q53448356 | ||
| Colorectal cancer | Q57191694 | ||
| Prognosis and survival in patients with gastrointestinal tract carcinoid tumors | Q57656761 | ||
| Complications and diagnosis of Meckel's diverticulum in 776 patients | Q67567496 | ||
| Somatostatin receptor scintigraphy and therapy of neuroendocrine (APUD) tumors of the head and neck | Q71307287 | ||
| The prognostic significance of direct extension of carcinoma of the colon and rectum | Q73485549 | ||
| Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma | Q74305708 | ||
| Meckel's diverticulitis secondary to carcinoid tumor: an unusual presentation of the acute abdomen in an adult | Q76367256 | ||
| P921 | main subject | adenocarcinoma | Q356033 |
| Meckel's diverticulum | Q388628 | ||
| P304 | page(s) | 358 | |
| P577 | publication date | 2014-11-27 | |
| P1433 | published in | World Journal of Surgical Oncology | Q14520241 |
| P1476 | title | Gastroenteropancreatic neuroendocrine tumour arising in Meckel's diverticulum coexisting with colon adenocarcinoma | |
| P478 | volume | 12 |
| Q40979954 | A Rare Case of Mixed Neuroendocrine Tumor and Adenocarcinoma of the Pancreas |
| Q57652954 | Malignancy and Meckel's diverticulum: A systematic literature review and 14-year experience at a tertiary referral center |
| Q37483339 | Serous Cystadenocarcinoma Arising in Presumed Vitelline Duct Remnant: A Case Report and Implications in the Management of Cancer of Unknown Primary. |
Search more.